Titration News and Research

RSS
Central BP achieves the same with less

Central BP achieves the same with less

Studies show that hTEE technology changes patient management in critical care

Studies show that hTEE technology changes patient management in critical care

Texas scientists develop new medium for cultivation of beneficial microorganisms

Texas scientists develop new medium for cultivation of beneficial microorganisms

Upsher-Smith completes USL255 Phase III clinical trial in patients with refractory POS

Upsher-Smith completes USL255 Phase III clinical trial in patients with refractory POS

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

New form of electroconvulsive therapy could prevent adverse cognitive side effects

New form of electroconvulsive therapy could prevent adverse cognitive side effects

Pre-treatments for peripheral neuropathic pain patch receive European Commision approval

Pre-treatments for peripheral neuropathic pain patch receive European Commision approval

Structured hypertension care: VIPER lacks real bite

Structured hypertension care: VIPER lacks real bite

Structured hypertension care: VIPER lacks real bite

Structured hypertension care: VIPER lacks real bite

Arisaph’s ARI-3037MO well tolerated in healthy male and female volunteers

Arisaph’s ARI-3037MO well tolerated in healthy male and female volunteers

Eisai receives FDA approval for Fycompa to treat partial onset seizures

Eisai receives FDA approval for Fycompa to treat partial onset seizures

Trevena reports completion of TRV027 Phase 2a study in advanced heart failure patients

Trevena reports completion of TRV027 Phase 2a study in advanced heart failure patients

MannKind completes enrollment in AFREZZA Phase 3 clinical studies for type 1 and 2 diabetes

MannKind completes enrollment in AFREZZA Phase 3 clinical studies for type 1 and 2 diabetes

NOXXON commences NOX-A12 Phase IIa trial in relapsed MM

NOXXON commences NOX-A12 Phase IIa trial in relapsed MM

Tight blood sugar control does not benefit pediatric patients undergoing heart surgery

Tight blood sugar control does not benefit pediatric patients undergoing heart surgery

Treatments for peripheral neuropathic pain compared

Treatments for peripheral neuropathic pain compared

UCB’s Neupro now available in U.S. pharmacies

UCB’s Neupro now available in U.S. pharmacies

NOXXON commences Spiegelmer NOX-A12 Phase IIa trial in CLL

NOXXON commences Spiegelmer NOX-A12 Phase IIa trial in CLL

Home BP monitoring ‘could help guide dosing, titration’

Home BP monitoring ‘could help guide dosing, titration’

Promising preliminary data for axitinib in metastatic kidney cancer

Promising preliminary data for axitinib in metastatic kidney cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.